Mario Thomas presentation 2013

MARIO THOMAS, PH.D., C.DIR.

Building value through dynamic leadership and strategic partnerships

ACCOMPLISHED STRATEGIC EXECUTIVEACCOMPLISHED STRATEGIC EXECUTIVESPECIALIZING in BUSINESS DEVELOPMENT and COMMERCIALIZATION SPECIALIZING in BUSINESS DEVELOPMENT and COMMERCIALIZATION

Building value through dynamic leadership andstrategic partnerships

Please click for each consecutive slide



Corporate leader advancing critical initiatives in commercialization of innovation

Drives international business development, venture financing, and corporate transitions

Builds world-class teams to deliver optimum performance and global collaboration

Advances projects through overwhelming odds with decisiveness and dedication

Brings innovative solutions to complex business challenges with bottom-line results

Orchestrates strategic alliances built on lucrative opportunities and advantageous deals

Integrates science and business to grow prosperous and profitable ventures



Growth Development & Strategy

Organizational Transformation

Product Research & Development

Tactical Negotiations & Closures

Product Commercialization

Global Market Expansion

Profit & Loss Management

Sales & Marketing

High Growth Ventures

Financial Restructuring

Board of Directors Interface

Return on Investment



EXECUTIVE CAREER SYNOPSIS

Ontario Centres of Excellence, Toronto, ON, Canada 2009 - 2013 The pre-eminent research-t0-market vehicle in Ontario.

SENIOR VICE PRESIDENT, STRATEGY, PROGRAMS & PARTNERSHIPS MANAGING DIRECTOR, CENTRE FOR COMMERCIALIZATION OF RESEARCH

T2C2 / Bio Venture Capital, Montreal, QC, Canada 2002 - 2009A $100M venture fund which focuses on early-stage life sciences investments in Canada, Europe, and Israel.

PARTNER & VICE PRESIDENT

EntoMed, Strasbourg, France 2000 - 2002World leader in the discovery and development of medicines derived from the biology and chemical diversity of insects.

CO-FOUNDER, CHAIRMAN & CEO

TerraGen Discovery Inc., Vancouver, BC, Canada 1998 - 2000International biotechnology firm with global projects in the fight against infections.

PRESIDENT & CEO

BioChem Pharma Inc., Montreal, QC, Canada 1993 - 1998An international biopharmaceutical company dedicated to the research, development, and commercialization of new

drugs VICE PRESIDENT, STRATEGY PLANNING & BUSINESS DEVELOPMENT



OUTSTANDING CONTRIBUTIONS TO CORPORATE GAINS (1 of 4)

Built a new non-profit organization from the ground up to engage clients, partners and stakeholders.In three years of operation the following outcomes were generated:

New jobs created 1500 Follow-on investment: $149 million New entrepreneurs: 23 Companies Served: 992 Companies Funded: 86 $ Invested: $7 million $ Leveraged: $28 million

CLIENTS:

START-UP ENTREPRENEURS

CONNEC

T GROW

SUCCEED!

Regional Partners

Advice + Resources

Embedded Executives

Seed Investments

National + Global Networks




Implemented a strategic planning process incorporating business development objectives while integrating long-term strategy with annual operating plans. Concluded 20 lucrative transactions in

different countries in the world over a 5-year period. Launched the Canadian commercial operation for the number one drug, 3TC used against HIV and aids becoming a multi-billion dollar product worldwide

and more successful than any other treatment while significantly reducing the death rate.


Building value through dynamic leadership, strategic alliances, and lucrative results


Led a $100 Million independent venture fund in portfolio analysis to spearhead the lucrative M&A process creating new healthcare and biopharmaceutical organizations with valuations ranging up to $50 Million.

Devised the strategies for as many as twelve, multi-million dollar investment candidates in Bio/Agro, chemistry, medical equipment, genomics, and therapeutic products while reducing corporate risk.



“Mario Thomas is a highly experienced and sophisticated business professional; he is a great strategist with an ability to understand what is important in a business

deal from all perspectives.”

Lesley Phillips, ALLIANCE MANAGER, Terragen Discovery




CHALLENGE: • Joined Terragen Discovery Inc., a private biopharmaceutical R&D stage company lacking a scientific proof of principle for its approach to drug discovery with no patent covering the core technology.

STRATEGIES: • Completed a thorough and extensive analysis of strategic options to design a business plan aimed at solving these deficiencies, gaining swift Board approval followed by rapid execution.

• Established two significant research collaborations to advance anti-infective research initiatives while raising $13 Million in venture capital.

RESULTS: • Grew corporate value through a series of strategic manoeuveurs including the multi-million dollar acquisitions of a US competitor to obtain broad issued patents covering the core technology and a UK company for its downstream drug discovery capabilities.

= VALUE



“Mario, provided leadership and applied business acumen to organize the company's research,

hire additional research management, and acquire additional critical mass.”

“These actions built value for the investors and enabled the successful sale of the company.”

Geoff Collett , Vice President, MDS Capital



IMPRESSIVE CREDENTIALS

INTERNATIONAL SCOPE

Architected and co-founded the International Commercialization Alliance a not for profit organization grouping 49 innovation intermediaries from 18 countries

Established a broad network of scientific and industrial collaborations to source DNA:Australia, China, Israel, Russia, France, Belgium, Holland, UK,

South Africa, South and North America

Dual citizenship in the EU and Canada, Fluent in both English and French

ACADEMIC CREDENTIALS

Ph.D. (Chemistry)Université Laval (1972-1975)

B.Sc. (Sciences)Université Laval (1969-1972)

DSA (Business Administration Diploma)Université de Montreal HEC (1976-1981)

C.DIR. (Chartered Director)Université Laval - Directors’ College (2006-2007)



ABOUT: MARIO THOMAS

Mario Thomas is an accomplished senior executive with impressive international credentials in the commercialization of innovation. With over 30 years in leadership roles, he creates remarkable value for all stakeholders. He brings extensive experience filled with illustrious achievements in the innovation sector driving successful development collaborations and financial ventures.

In a day and age when strategic alliances are critical to business development, Mario offers invaluable leadership to direct corporate growth. This is particularly true in the commercialization of new ideas where breakthrough products and services are needed to create new markets and strengthen existing ones. Mario Thomas fulfills this need and much more as he builds value by leading strategic alliances with future vision and lucrative results.



“Mario is a professional deal maker. He knows the life sciences industry and is able, as an investor, to work with management teams with a view to contributing to growth.”“He is business savvy, networked thorough and a very hard worker.”

Shahir Guindi, Partner, Osler, Hoskin & Harcourt LLP



ACCOMPLISHED STRATEGIC EXECUTIVEACCOMPLISHED STRATEGIC EXECUTIVESPECIALIZING in BUSINESS DEVELOPMENT & COMMERCIALIZATIONSPECIALIZING in BUSINESS DEVELOPMENT & COMMERCIALIZATION

Thank you for your time and consideration in viewing this presentation.

For more information about this strategic executive in order to add value to your business, please contact Mario at:

277 Lawrence Avenue East, TORONTO, ON CANADA M4N 1T6 H: 416-487-8785 C: 416-886-7724 [email protected]